http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019237749-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44ae178fe5ea1fd193b8e5e1baf1ab3b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00891
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2019-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_573fe13ae7da3db36c74c81ca5148a0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca44969327f89083596ccc975a6865c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3909ee51207cd67d6122e5764325fa88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0d5308e88393cfd60e5d5b8b149cd4
publicationDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019237749-A1
titleOfInvention Lamina cribrosa crossing pressure balance maintainer for constantly balancing lamina cribrosa crossing pressure difference, implantation device, and method for balancing lamina cribrosa crossing pressure difference
abstract A Lamina cribrosa crossing pressure balance maintainer for constantly balancing the Lamina cribrosa crossing pressure difference, an implantation device, and a method for balancing the Lamina cribrosa crossing pressure difference. The Lamina cribrosa crossing pressure balance maintainer is placed at the Lamina cribrosa to balance the Lamina cribrosa crossing pressure difference so as to enable the deformed Lamina cribrosa to recover or even reverse, so that the tolerance of glaucoma patients to intraocular hypertension is improved, nerve damage caused by the Lamina cribrosa crossing pressure difference is relieved and reduced, and primary factors of the glaucoma optic nerve damage are eliminated. New ideas are provided for the treatment of the glaucoma in the middle and advanced periods.
priorityDate 2018-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003229303-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002143284-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 23.